Browse Drug Recalls
2,085 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 2,085 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 2,085 FDA drug recalls in 2013.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 21, 2013 | 0.9% Sodium Chloride Injection, USP, in MINI-BAG Plus Container, a) 50 mL (ND... | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for p... | Class II | Baxter Healthcare Corp. |
| May 21, 2013 | Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count u... | Crystallization; crystallized nimodipine | Class II | Sun Pharmaceutical Industries Inc. |
| May 21, 2013 | Heparin Sodium and 0.9% Sodium Chloride Injection, a) Product code 2B0944, 20... | Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for p... | Class II | Baxter Healthcare Corp. |
| May 20, 2013 | Ondansetron Injection, USP, 4mg/2mL, (2mg/ml), 2mL single-dose Fliptop Vial, ... | Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles f... | Class II | Hospira, Inc. |
| May 20, 2013 | Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL S... | Presence of Particulate Matter: Found during examination of retention samples. | Class I | Sandoz Incorporated |
| May 20, 2013 | JaDera, 100% Natural Weight Loss Supplement, capsules, 30 count bottle | Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutram... | Class I | Dolphin Intertrade Corporation |
| May 20, 2013 | XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box | Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutram... | Class I | Dolphin Intertrade Corporation |
| May 17, 2013 | Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician S... | Failed Impurities/Degradation Specifications: unspecified degradation product | Class II | Warner Chilcott US LLC |
| May 16, 2013 | West-ward Belladonna Alkaloids with Phenobarbital Tablets, a) 1000-count bott... | Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks ... | Class II | West-Ward Pharmaceutical Corp. |
| May 16, 2013 | West-ward Belladonna Alkaloids with Phenobarbital Tablets, a) 1000-count bott... | Cross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets containe... | Class II | West-Ward Pharmaceutical Corp. |
| May 16, 2013 | Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, ... | Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. | Class II | Hospira Inc. |
| May 15, 2013 | Proplete 34 - 39 KG (Intradialytic Parenteral Nutrition composed of amino aci... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Baxter LL bag 1.5% Amino Acids (Intraperitoneal Parenteral Nutrition - dialys... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Baxter Ultrabag 1.5% Amino Acids (Intraperitoneal Parenteral Nutrition - dial... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Theraflu Nighttime Warming Relief Nighttime Multi-Symptom Cold, Acetaminophen... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. | Class III | Novartis Consumer Health |
| May 15, 2013 | Maximum Strength Comtrex Day/Night Cold & Cough, Acetaminophen 325mg, Chlorph... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. | Class III | Novartis Consumer Health |
| May 15, 2013 | Baxter LL bag 1% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysat... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Proplete 80+ KG (Intraperitoneal Parenteral Nutrition - dialysate solution wi... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Baxter LL bag 1% Amino Acids w/KCL (Intraperitoneal Parenteral Nutrition - di... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Fresenius bag 1% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysat... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Proplete 90+ KG (Intraperitoneal Parenteral Nutrition - dialysate solution wi... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Baxter LL bag 2% Amino Acids (Intraperitoneal Parenteral Nutrition - dialysat... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Proplete 45 - 51 KG (Intraperitoneal Parenteral Nutrition - dialysate solutio... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Proplete 70+ KG (Intraperitoneal Parenteral Nutrition - dialysate solution wi... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Proplete 52 - 59 KG (Intradialytic Parenteral Nutrition - dialysate solution ... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 cap... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing | Class III | Novartis Consumer Health |
| May 15, 2013 | IDPN (Intradialytic Parenteral Nutrition - dialysate solution with added amin... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Theraflu Warming Relief, Multi-Symptom Cold, Acetaminophen 325mg, Dextrometho... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing | Class III | Novartis Consumer Health |
| May 15, 2013 | HEALTH & BEYOND DR. LARRY'S Tranquility DIETARY SUPPLEMENT 30 Capsules Manufa... | Marketed Without an Approved NDA/ANDA; product found to contain Doxepin (an antidepressant) and C... | Class II | Health & Beyond |
| May 15, 2013 | Budesonide Capsules, 3 mg, Enteric Coated, packaged in 30-count capsules unit... | Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an ... | Class III | Mylan Institutional, Inc. (d.b.a. UDL Laborator... |
| May 15, 2013 | Proplete 60 - 69 KG (Intradialytic Parenteral Nutrition - dialysate solution ... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Maximum Strength Comtrex Nighttime Cold & Cough, Acetaminophen 325mg ,Chlorph... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. | Class III | Novartis Consumer Health |
| May 15, 2013 | Maximum Strength Comtrex , Day/Night Flu Therapy , Acetaminophen 325mg, Chlor... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. | Class III | Novartis Consumer Health |
| May 15, 2013 | Proplete 40 - 44 KG (Intradialytic Parenteral Nutrition - dialysate solution ... | Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutri... | Class II | Pentec Health |
| May 15, 2013 | Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactu... | Failed Impurity/Degradation Specification; "Related Compound C" | Class II | Actavis South Atlantic LLC |
| May 15, 2013 | Maximum Strength Comtrex ,Severe Cold & Sinus Acetaminophen 325mg, Chlorphen... | Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing. | Class III | Novartis Consumer Health |
| May 13, 2013 | Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufa... | Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who disc... | Class I | Zydus Pharmaceuticals USA Inc |
| May 13, 2013 | Trace Mineral-5 MDV, supplied in 10 mL vials, Each ML contains: 1 mg Zinc (as... | Non-Sterility; contract laboratory identified Staphylococcus warneri in the product | Class I | Abrams Royal Pharmacy |
| May 13, 2013 | Nicardipine Hydrochloride Injection 25 mg/10 mL (2.5 mg/mL), 10 mL single-use... | Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpu... | Class III | West-ward Pharmaceutical Corp. |
| May 10, 2013 | Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk ... | Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon rec... | Class I | Apotex Corp. |
| May 8, 2013 | Dicopanol FusePaq Kit for Oral Suspension, 5mg/ML | Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopano... | Class II | Fusion Pharmaceuticals, LLC |
| May 7, 2013 | Derma-Smoothe/FS (fluocinolone acetonide) Topical Oil (SCALP OIL), 0.01 %, 11... | Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during t... | Class III | Hill Dermaceuticals, Inc. |
| May 6, 2013 | Lightning ROD capsules, 500 mg/capsule, packaged in 3-count bottles (UPC 6 89... | Marketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA anal... | Class I | Chang Kwung Products |
| May 6, 2013 | Lightning ROD capsules, 550 mg/capsule, packaged in 12-count bottles (UPC 6 8... | Marketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA anal... | Class I | Chang Kwung Products |
| May 3, 2013 | Pure-Aid Allergy Relief, Diphenhydramine HCL Caplets, 25 mg, 20 caplets, Excl... | Labeling: Not Elsewhere Classified; foil label on immediate blister pack indicates active ingredi... | Class II | Kareway Product Inc |
| May 2, 2013 | Morphine Sulfate 25 mg/mL Injectable, 40 mL vial, compounded by The Compoundi... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | THE COMPOUNDING SHOP, INC. |
| May 2, 2013 | Sodium EDTA 150 mg/mL Injectable, 250 mL vial, compounded by The Compounding ... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | THE COMPOUNDING SHOP, INC. |
| May 2, 2013 | B-Complex 100 mg/mL Injectable, 50 mL vials, compounded by The Compounding Sh... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | THE COMPOUNDING SHOP, INC. |
| May 2, 2013 | Phosphatidyl Choline 10%, Injectable, 500 mL vial, compounded by The Compound... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | THE COMPOUNDING SHOP, INC. |
| May 2, 2013 | Baclofen 500 mcg/mL Injectable, 22 mL vial, Compounded by The Compounding Sho... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality co... | Class II | THE COMPOUNDING SHOP, INC. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.